XERIS BIOPHARMA HOLDINGS, INC. Foreign Pre-Tax Income
XERIS BIOPHARMA HOLDINGS, INC. (XERS) reported Foreign Pre-Tax Income of $46.46 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign · last filed 2026-03-02
- XERIS BIOPHARMA HOLDINGS, INC. income (loss) from continuing operations before income taxes, foreign for fiscal 2025 was $46.46M, a 118.08% increase from fiscal 2024.
- XERIS BIOPHARMA HOLDINGS, INC. income (loss) from continuing operations before income taxes, foreign for fiscal 2024 was $21.30M, a 467.05% increase from fiscal 2023.
- XERIS BIOPHARMA HOLDINGS, INC. income (loss) from continuing operations before income taxes, foreign for fiscal 2023 was $3.76M.
- XERIS BIOPHARMA HOLDINGS, INC. income (loss) from continuing operations before income taxes, foreign for fiscal 2022 was -$19.00M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Foreign 12 month |
|---|---|
| 2025-12-31 | $46.46M 10-K · filed 2026-03-02 |
| 2024-12-31 | $21.30M 10-K · filed 2026-03-02 |
| 2023-12-31 | $3.76M 10-K · filed 2026-03-02 |
| 2022-12-31 | -$19.00M 10-K · filed 2025-03-06 |
| 2021-12-31 | -$7.99M 10-K · filed 2024-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |